Identification of a constitutively active mutant of JAK3 by retroviral expression screening
- 28 February 2007
- journal article
- Published by Elsevier BV in Leukemia Research
- Vol. 31 (2), 203-209
- https://doi.org/10.1016/j.leukres.2006.05.006
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 20 references indexed in Scilit:
- Converging pathways in leukemogenesis and stem cell self-renewalExperimental Hematology, 2005
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisCancer Cell, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Autophosphorylation of JAK2 on Tyrosines 221 and 570 Regulates Its ActivityMolecular and Cellular Biology, 2004
- Cytogenetics in acute leukemiaBlood Reviews, 2003
- The Pseudokinase Domain Is Required for Suppression of Basal Activity of Jak2 and Jak3 Tyrosine Kinases and for Cytokine-inducible Activation of Signal TransductionJournal of Biological Chemistry, 2002
- Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cellsOncogene, 2001
- Jaks and stats in cytokine signalingThe International Journal of Cell Cloning, 1997
- Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cellsNature, 1994